Identification of differential PI3K pathway target dependencies in T-cell acute lymphoblastic leukemia through a large cancer cell panel screen

Selective phosphoinositide 3-kinase (PI3K)/AKT/mTOR inhibitors are currently under evaluation in clinical studies. To identify tumor types that are sensitive to PI3K pathway inhibitors we screened compounds targeting PI3Kα/δ (AZD8835), PI3Kβ/δ (AZD8186), AKT (AZD5363) and mTORC1/2 (AZD2014) against...

Descripción completa

Detalles Bibliográficos
Autores principales: Lynch, James T., McEwen, Robert, Crafter, Claire, McDermott, Ultan, Garnett, Mathew J., Barry, Simon T., Davies, Barry R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008349/
https://www.ncbi.nlm.nih.gov/pubmed/26989080
http://dx.doi.org/10.18632/oncotarget.8031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008349/
https://www.ncbi.nlm.nih.gov/pubmed/26989080
http://dx.doi.org/10.18632/oncotarget.8031

Ejemplares similares